On October 6, 2026, Kaiser Permanente and Tufts Medical Center leaders will host a free webinar discussing challenges and opportunities of expensive but effective medications like GLP-1s. The event will focus on how value-based care systems aim to improve patient outcomes, access, and affordability. This discussion is important as healthcare systems balance cost and quality in treatment options. Interested participants can register to join the live fireside chat at 10 a.m. PT.
J.Jill reported strong Q2 earnings, beating estimates with $1.24 EPS and $154.83M revenue, driven by sales growth and direct sales increase. Following this, BTIG raised its price target to $25, suggesting a 15.74% upside. The company also raised its ...
BMO Capital Markets initiated coverage of Lululemon Athletica with an Underperform rating and a $70 price target, citing weakening demand in key markets and margin pressures. This follows a 4% revenue decline in Q2 and a reduced full-year forecast. M...
Core & Main reported strong Q2 earnings with EPS of $0.94, surpassing the $0.92 analyst estimate and showing an 8% increase year-over-year. Revenue reached $2.15 billion, slightly above the $2.14 billion expected, supported by robust municipal infras...
Korn Ferry reported strong Q1 results with earnings per share of $1.43 and revenue of $756.5 million, both exceeding analyst expectations and marking continued growth. Despite this, the stock fell due to conservative guidance for the next quarter, wh...
SailPoint reported Q2 2026 earnings with revenue of $308.81 million, slightly below estimates but up 17% year-over-year. Adjusted EPS of $0.09 beat analyst expectations by 12.5%, reflecting improved profitability. The company showed strong subscripti...
